michael_duerr's profile picture. passionate transplant nephrologist and dad of a wonderful daughter. Newbie in Cell&Gene Therapies @Bayer ex@ChariteBerlin #AAV #GCT Views here are my own

Michael Duerr

@michael_duerr

passionate transplant nephrologist and dad of a wonderful daughter. Newbie in Cell&Gene Therapies @Bayer ex@ChariteBerlin #AAV #GCT Views here are my own

Michael Duerr đã đăng lại

How does GLP-1 produce a CV benefit? Reduced body weight, glycaemia, BP, postprandial lipaemia and inflammation. Cardioprotective mechanisms are multiple and not perfectly understood, but undeniable, as shown by SELECT study. nature.com/articles/s4156… @sociedadSEEN @SociedadSeedo

ObesitySeen's tweet image. How does GLP-1 produce a CV benefit?
Reduced body weight, glycaemia,
BP, postprandial lipaemia and inflammation.
Cardioprotective mechanisms are multiple and not perfectly understood, but undeniable, as shown by SELECT study.
nature.com/articles/s4156…
@sociedadSEEN @SociedadSeedo

Michael Duerr đã đăng lại

Fresh from the press in @NatRevImmunol The 5 types of glomerulonephritis that connect pathogenesis with immunotherapy thanks to @PRomagnani @KitchingLab and Nelson Leung from Mayo nature.com/articles/s4157…


Michael Duerr đã đăng lại

Four years ago, I spent the holidays intubated in an ICU with a sudden diagnosis of cardiogenic shock due to heart failure. Today, I thank my organ donor, Lucy, for giving me this #giftoflife ♻️ through heart transplantation. #thankyou #organdonation

AG_EM33's tweet image. Four years ago, I spent the holidays intubated in an ICU with a sudden diagnosis of cardiogenic shock due to heart failure. Today, I thank my organ donor, Lucy, for giving me this #giftoflife ♻️ through heart transplantation. #thankyou #organdonation

Michael Duerr đã đăng lại

Love this. Turn up the sound.

Tweet này không còn khả dụng.

Michael Duerr đã đăng lại

The last outstanding #ESGCT2022 congress is over. It was an incredible success, and nothing could have been possible without your enthusiasm, dedication and passion for science.

ESGCT's tweet image. The last outstanding #ESGCT2022 congress is over. It was an incredible success, and nothing could have been possible without your enthusiasm, dedication and passion for science.

It was a great week to learn and to connect at #ESGCT2022 #Edinburgh. Thanks the organizers @ESGCT to put an amazing program together. Safe travels for all attendees ✈️We are motivated and will facilitate #GCT for our patients💪💊 @BayerPharma


The Founder Award of #ESGCT2022 goes to Jude Samulski for his pioneering work on #AAV for #CGT. 🍾🎊Congrats Jude!!! Feel privileged and thankful to come to know him🙏@ask_bio @BayerPharma

michael_duerr's tweet image. The Founder Award of #ESGCT2022 goes to Jude Samulski for his pioneering work on #AAV for #CGT. 🍾🎊Congrats Jude!!!  Feel privileged and thankful to come to know him🙏@ask_bio @BayerPharma
michael_duerr's tweet image. The Founder Award of #ESGCT2022 goes to Jude Samulski for his pioneering work on #AAV for #CGT. 🍾🎊Congrats Jude!!!  Feel privileged and thankful to come to know him🙏@ask_bio @BayerPharma

Outstanding Achievement Award 2022 #ESGCT2022 goes to Christof von Kalle #BIH @berlinnovation and to Manfred Schmidt posthumous to help leveraging the potential of #LMPCR by enabling studies of viral integration/viral vector tracking in #GCT. Very emotional ceremony!

michael_duerr's tweet image. Outstanding Achievement Award 2022 #ESGCT2022 goes to Christof von Kalle #BIH @berlinnovation and to Manfred Schmidt posthumous to help leveraging the potential of #LMPCR by enabling studies of viral integration/viral vector tracking in #GCT. Very emotional ceremony!
michael_duerr's tweet image. Outstanding Achievement Award 2022 #ESGCT2022 goes to Christof von Kalle #BIH @berlinnovation and to Manfred Schmidt posthumous to help leveraging the potential of #LMPCR by enabling studies of viral integration/viral vector tracking in #GCT. Very emotional ceremony!
michael_duerr's tweet image. Outstanding Achievement Award 2022 #ESGCT2022 goes to Christof von Kalle #BIH @berlinnovation and to Manfred Schmidt posthumous to help leveraging the potential of #LMPCR by enabling studies of viral integration/viral vector tracking in #GCT. Very emotional ceremony!

Presidential address given by Hildegard Büning. We are all very happy&thankful to be back at #ESGCT2022 to exchange newest data&network 🙏#GCT has a bright future with the potential to treat those pts who otherwise would never have a chance #Edinburgh #ASGCT #AAV #CRISP

michael_duerr's tweet image. Presidential address given by Hildegard Büning. We are all very happy&thankful to be back at #ESGCT2022 to exchange newest data&network 🙏#GCT has a bright future with the potential to treat those pts who otherwise would never have a chance #Edinburgh #ASGCT #AAV #CRISP
michael_duerr's tweet image. Presidential address given by Hildegard Büning. We are all very happy&thankful to be back at #ESGCT2022 to exchange newest data&network 🙏#GCT has a bright future with the potential to treat those pts who otherwise would never have a chance #Edinburgh #ASGCT #AAV #CRISP

APOE4 gene is linked to higher risk for #Alzheimer Mike Kaplitt @WeillCornell presented first results on gene therapy with #AAV coding for APOE2 delivered via CSF to treat APOE4 #Alzheimer pts. Promising interim results #ESGCT2022

michael_duerr's tweet image. APOE4 gene is linked to higher risk for #Alzheimer Mike Kaplitt @WeillCornell presented first results on gene therapy with #AAV coding for APOE2 delivered via CSF to treat APOE4 #Alzheimer pts. Promising interim results #ESGCT2022
michael_duerr's tweet image. APOE4 gene is linked to higher risk for #Alzheimer Mike Kaplitt @WeillCornell presented first results on gene therapy with #AAV coding for APOE2 delivered via CSF to treat APOE4 #Alzheimer pts. Promising interim results #ESGCT2022
michael_duerr's tweet image. APOE4 gene is linked to higher risk for #Alzheimer Mike Kaplitt @WeillCornell presented first results on gene therapy with #AAV coding for APOE2 delivered via CSF to treat APOE4 #Alzheimer pts. Promising interim results #ESGCT2022
michael_duerr's tweet image. APOE4 gene is linked to higher risk for #Alzheimer Mike Kaplitt @WeillCornell presented first results on gene therapy with #AAV coding for APOE2 delivered via CSF to treat APOE4 #Alzheimer pts. Promising interim results #ESGCT2022

Learned a lot about new #gene #editing strategies on #huntington disease with #AAV Kami #Cas9 and with the help of human brain atlas to predict efficiency. Great educative talk-thanks to Nicole Deglon #ESGCT2022

michael_duerr's tweet image. Learned a lot about new #gene #editing strategies on #huntington disease with #AAV Kami #Cas9 and with the help of human brain atlas to predict efficiency. Great educative talk-thanks to Nicole Deglon #ESGCT2022
michael_duerr's tweet image. Learned a lot about new #gene #editing strategies on #huntington disease with #AAV Kami #Cas9 and with the help of human brain atlas to predict efficiency. Great educative talk-thanks to Nicole Deglon #ESGCT2022
michael_duerr's tweet image. Learned a lot about new #gene #editing strategies on #huntington disease with #AAV Kami #Cas9 and with the help of human brain atlas to predict efficiency. Great educative talk-thanks to Nicole Deglon #ESGCT2022
michael_duerr's tweet image. Learned a lot about new #gene #editing strategies on #huntington disease with #AAV Kami #Cas9 and with the help of human brain atlas to predict efficiency. Great educative talk-thanks to Nicole Deglon #ESGCT2022

Greg Gojanovic #AskBio showed with an empty #AAV capsid study a strong Ab & CD4 response despite absence of transgene. CD4/ICOS/PD1 was a identified phenotype who drives anti capsid response. Great talk&nice example how we can implement deep immune phenotyping in #CGT #ESGCT2022

michael_duerr's tweet image. Greg Gojanovic #AskBio showed with an empty #AAV capsid study a strong Ab & CD4 response despite absence of transgene. CD4/ICOS/PD1 was a identified phenotype who drives anti capsid response. Great talk&nice example how we can implement deep immune phenotyping in #CGT #ESGCT2022
michael_duerr's tweet image. Greg Gojanovic #AskBio showed with an empty #AAV capsid study a strong Ab & CD4 response despite absence of transgene. CD4/ICOS/PD1 was a identified phenotype who drives anti capsid response. Great talk&nice example how we can implement deep immune phenotyping in #CGT #ESGCT2022
michael_duerr's tweet image. Greg Gojanovic #AskBio showed with an empty #AAV capsid study a strong Ab & CD4 response despite absence of transgene. CD4/ICOS/PD1 was a identified phenotype who drives anti capsid response. Great talk&nice example how we can implement deep immune phenotyping in #CGT #ESGCT2022

Treatment of devastating disease called #epidermolysis #bullosa with topical B-VEC, a HSV based redosable gene therapy to induce COL7 in skin showed impressive P3 trial results. Wounds healed with expressions of transfected collagen. #ESGCT2022

michael_duerr's tweet image. Treatment of devastating disease called #epidermolysis #bullosa with topical B-VEC, a HSV based redosable gene therapy to induce COL7 in skin showed impressive P3 trial results. Wounds healed with expressions of transfected collagen. #ESGCT2022
michael_duerr's tweet image. Treatment of devastating disease called #epidermolysis #bullosa with topical B-VEC, a HSV based redosable gene therapy to induce COL7 in skin showed impressive P3 trial results. Wounds healed with expressions of transfected collagen. #ESGCT2022
michael_duerr's tweet image. Treatment of devastating disease called #epidermolysis #bullosa with topical B-VEC, a HSV based redosable gene therapy to induce COL7 in skin showed impressive P3 trial results. Wounds healed with expressions of transfected collagen. #ESGCT2022
michael_duerr's tweet image. Treatment of devastating disease called #epidermolysis #bullosa with topical B-VEC, a HSV based redosable gene therapy to induce COL7 in skin showed impressive P3 trial results. Wounds healed with expressions of transfected collagen. #ESGCT2022

#Moderna works on #LNPs which can be delivered to different tissues. Also, one #LNP can be inhaled to target lung tissue. No safety concerns so far. #ESGCT2022

michael_duerr's tweet image. #Moderna works on #LNPs which can be delivered to different tissues. Also, one #LNP can be inhaled to target lung tissue. No safety concerns so far. #ESGCT2022
michael_duerr's tweet image. #Moderna works on #LNPs which can be delivered to different tissues. Also, one #LNP can be inhaled to target lung tissue. No safety concerns so far. #ESGCT2022
michael_duerr's tweet image. #Moderna works on #LNPs which can be delivered to different tissues. Also, one #LNP can be inhaled to target lung tissue. No safety concerns so far. #ESGCT2022

Great educative talk on oncolytic viruses and platforms towards new immuntherapies for cancer patients by @vincersurf #ESGCT2022

michael_duerr's tweet image. Great educative talk on oncolytic viruses and platforms towards new immuntherapies for cancer patients by @vincersurf #ESGCT2022
michael_duerr's tweet image. Great educative talk on oncolytic viruses and platforms towards new immuntherapies for cancer patients by @vincersurf #ESGCT2022
michael_duerr's tweet image. Great educative talk on oncolytic viruses and platforms towards new immuntherapies for cancer patients by @vincersurf #ESGCT2022

Traveling to #ESGCT2022 #Edinburgh. I’m so happy to learn more about the fascinating field of cell and gene therapies #CGT and to connect with colleagues and new people in the area. @ask_bio @BayerPharma #AAV esgctcongress.com


Loading...

Something went wrong.


Something went wrong.